These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36111932)
1. Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations - a cohort study in Bulgarian patients. Atanassova A; Georgieva A Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6310-6315. PubMed ID: 36111932 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location. Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427 [TBL] [Abstract][Full Text] [Related]
3. Tissue and serum miR-149-3p/5p in hospitalized patients with inflammatory bowel disease: Correlation with disease severity and inflammatory markers. Luo S; Chen XH Kaohsiung J Med Sci; 2024 Feb; 40(2):131-138. PubMed ID: 37997516 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis. Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994 [TBL] [Abstract][Full Text] [Related]
5. Circulating miR-199a and long noncoding-RNA ANRIL as Promising Diagnostic Biomarkers for Inflammatory Bowel Disease. Erfan R; Shaker OG; Khalil MAF; Mahmoud FAM; Gomaa MS; Abu-El-Azayem AK; Zaki OM; Ahmed AM; Samy A; Mohammed A Inflamm Bowel Dis; 2024 Sep; 30(9):1500-1509. PubMed ID: 38190238 [TBL] [Abstract][Full Text] [Related]
6. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients. Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597 [TBL] [Abstract][Full Text] [Related]
7. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis. Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139 [TBL] [Abstract][Full Text] [Related]
8. Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia. Neubauer K; Bednarz-Misa I; Walecka-Zacharska E; Wierzbicki J; Agrawal A; Gamian A; Krzystek-Korpacka M Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621173 [TBL] [Abstract][Full Text] [Related]
9. Elevated miRNA Inversely Correlates with Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420 [TBL] [Abstract][Full Text] [Related]
10. microRNA in inflammatory bowel disease at a glance. Alamdari-Palangi V; Vahedi F; Shabaninejad Z; Dokeneheifard S; Movehedpour A; Taheri-Anganeh M; Savardashtaki A Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):140-148. PubMed ID: 32558695 [TBL] [Abstract][Full Text] [Related]
12. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease. Shaker OG; Safa A; Khairy A; Abozeid NF Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920 [TBL] [Abstract][Full Text] [Related]
13. Tissue and Circulating MicroRNA-31, MicroRNA-200b, and MicroRNA-200c Reflects Disease Activity in Crohn's Disease Patients: Results from the BIOMIR Study. Tocia C; Dumitru A; Mateescu B; Negreanu L; State M; Cozaru GC; Mitroi AF; Brinzan C; Popescu R; Leopa N; Iordache MM; Manea M; Matei E; Dumitru E; Alexandrescu L J Gastrointestin Liver Dis; 2023 Mar; 32(1):30-38. PubMed ID: 37004230 [TBL] [Abstract][Full Text] [Related]
14. Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease. Elamir A; Shaker O; Kamal M; Khalefa A; Abdelwahed M; Abd El Reheem F; Ahmed T; Hassan E; Ayoub S PLoS One; 2022; 17(10):e0275267. PubMed ID: 36206229 [TBL] [Abstract][Full Text] [Related]
15. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases. Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922 [TBL] [Abstract][Full Text] [Related]
16. LINC00641/miR-378a and Their Cross-Talk with TNF-α/IFN-γ as Potential Biomarkers in Ulcerative Colitis and Crohn's Diseases. Hameed NAA; Shaker OG; Hasona NA J Interferon Cytokine Res; 2023 Nov; 43(11):531-537. PubMed ID: 37956249 [TBL] [Abstract][Full Text] [Related]
17. Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease. Wang H; Zhang S; Yu Q; Yang G; Guo J; Li M; Zeng Z; He Y; Chen B; Chen M Medicine (Baltimore); 2016 Feb; 95(5):e2703. PubMed ID: 26844512 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect? de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer. Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]